OPKO Health, Inc.: OPKO Health and Entera Bio Expand Partnership to Advance First-in-Class Oral Long Acting PTH Tablet for Patients with Hypoparathyroidism

This is the third program that successfully combines Entera's oral peptide N-Tab- platform with OPKO's advanced protein chemistry capabilities The companies have accelerated this program and aim to ...

Novartis Pharma AG: Novartis delivered high single-digit sales growth, achieved 40% core margin and further advanced the pipeline in 2025

Ad hoc announcement pursuant to Art. 53 LR Full year Net sales grew +8% (cc1, +8% USD) with core operating income1 up +14% (cc, +12% USD) Sales growth driven by continued strong performance ...
ET HealthWorld

DR REDDY'S LABORATORIES

ETHealthworld.com brings latest dr reddy 039 s laboratories news, views and updates from all top sources for the Indian Health industry.
Taiwan News

Novartis delivered high single-digit sales growth, achieved 40% core margin and further advanced the pipeline in 2025

Sales growth driven by continued strong performance from priority brands including Kisqali (+57% cc), Kesimpta (+36% cc), Pluvicto (+42% cc), Scemblix (+85% cc) and Cosentyx (+8% cc) Core operating ...